<DOC>
	<DOCNO>NCT00005534</DOCNO>
	<brief_summary>To conduct population-based study prevalence asymptomatic ventricular dysfunction .</brief_summary>
	<brief_title>Prevalence Asymptomatic Ventricular Dysfunction</brief_title>
	<detailed_description>BACKGROUND : Chronic congestive heart failure ( CHF ) , cause left ventricular dysfunction ( LVD ) , major cause morbidity mortality . CHF major form cardiovascular disease increase prevalence , LVD progress asymptomatic phase severe symptomatic phase . Recent clinical trial proven angiotensin convert enzyme inhibitor reduce mortality , morbidity , disease progression asymptomatic patient objectively measure LVD . However , available estimate LVD prevalence base symptomatic patient , objectively measure ventricular function parameter . The distribution ventricular function parameter United States population unknown . Since prevalence objectively measure asymptomatic LVD unknown , total number patient LVD could benefit medical therapy also know . Furthermore , screen technique identify person treatable asymptomatic LVD evaluate population-based setting . The plasma concentration n-atrial natriuretic peptide ( n-ANP ) marker presence asymptomatic LVD may valuable screen tool asymptomatic LVD . DESIGN NARRATIVE : This population-based study distribution ventricular function parameter 2,050 adult resident Olmsted County , MN , collaboration Strong Heart study , 1,522 adult Northern Plains American Indians . This group Northern Plains Indians increase risk LVD , high prevalence cardiovascular disease general United States population . Subjects undergo echocardiography measure ventricular function parameter , well clinical assessment symptom , sign risk factor LVD . Plasma concentration n-ANP measure population determine accuracy n-ANP noninvasive marker asymptomatic LVD . These study provide : comparative population-based estimate ventricular function parameter LVD Olmsted County Northern Plains Indians ; estimate magnitude population patient could benefit current therapy ; current data risk factor prevalent CAD population ; foundation upon future study incidence clinical course asymptomatic LVD could base . They also assess accuracy plasma n-ANP identification asymptomatic LVD . The study renew May 2001 end March 2005 . Studies continue test hypothesis : abnormality leave ventricular systolic/diastolic function leave ventricular structure worsen time ; increase plasma brain natriuretic peptide associate progressive change leave ventricular structure function ; abnormal leave ventricular structure/function brain natriuretic peptide associate incident clinical event .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>